Literature DB >> 4044758

High-performance liquid chromatography of coenzyme Q-related compounds and its application to biological materials.

T Okamoto, K Fukui, M Nakamoto, T Kishi, T Okishio, T Yamagami, N Kanamori, H Kishi, E Hiraoka.   

Abstract

A convenient and precise method for the separation and determination of coenzyme Q (CoQ)-related compounds (CoQ homologues, plastoquinone-9, ubichromenol-9, etc.) was developed using high-performance liquid chromatography (HPLC). All compounds tested were separated using a reverse-phase column with a suitable mobile phase and detected at a wavelength of 275 nm. CoQ extracts in plasma and erythrocytes were purified by thin-layer chromatography prior to HPLC analysis, but such purification was not necessary when determining CoQ in urine and tissues. Hydroquinone forms of CoQ existing in animal tissues were oxidized to the corresponding quinone forms with potassium hexacyanoferrate(III). This HPLC method was applied satisfactorily to the determination of the contents of CoQ homologues in human and animal samples. CoQ10 was the only homologue detected in human samples, and CoQ8, CoQ9 and CoQ10 were native homologues of CoQ in rat tissues. Ubichromenol-9 and plastoquinone-9 were not detected in these samples.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4044758     DOI: 10.1016/s0378-4347(00)84487-4

Source DB:  PubMed          Journal:  J Chromatogr


  9 in total

Review 1.  The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Authors:  Iain P Hargreaves; Andrew J Duncan; Simon J R Heales; John M Land
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease.

Authors:  Teri L Wadsworth; James A Bishop; Anuradha S Pappu; Randall L Woltjer; Joseph F Quinn
Journal:  J Alzheimers Dis       Date:  2008-06       Impact factor: 4.472

3.  Coenzyme Q10: is there a clinical role and a case for measurement?

Authors:  Sarah L Molyneux; Joanna M Young; Christopher M Florkowski; Michael Lever; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

4.  Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.

Authors:  Chiaki Isobe; Takashi Abe; Yasuo Terayama
Journal:  J Neurol       Date:  2009-09-27       Impact factor: 4.849

5.  Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice.

Authors:  Piran Shelley; Malgorzata S Martin-Gronert; Anthea Rowlerson; Lucilla Poston; S J R Heales; Iain P Hargreaves; Josie M McConnell; Susan E Ozanne; Denise S Fernandez-Twinn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-17       Impact factor: 3.619

6.  Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors.

Authors:  R Laaksonen; J P Ojala; M J Tikkanen; J J Himberg
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  Cardiostimulatory action of coenzyme Q homologues on cultured myocardial cells and their biochemical mechanisms.

Authors:  T Kishi; T Okamoto; T Takahashi; K Goshima; T Yamagami
Journal:  Clin Investig       Date:  1993

8.  Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats.

Authors:  Kajal Rajdev; Ehraz Mehmood Siddiqui; Kuldeep Singh Jadaun; Sidharth Mehan
Journal:  IBRO Rep       Date:  2020-04-22

9.  Knockdown of FIBRILLIN4 gene expression in apple decreases plastoglobule plastoquinone content.

Authors:  Dharmendra K Singh; Tatiana N Laremore; Philip B Smith; Siela N Maximova; Timothy W McNellis
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.